Polyclonal Rabbit anti‑Mouse DRD5 / Dopamine Receptor D5 Antibody (aa19‑56, WB) LS‑C356637
Polyclonal Rabbit anti‑Mouse DRD5 / Dopamine Receptor D5 Antibody (aa19‑56, WB) LS‑C356637
Antibody:
DRD5 / Dopamine Receptor D5 Rabbit anti-Mouse Polyclonal (aa19-56) Antibody
Application:
WB, Peptide-ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
DRD5 / Dopamine Receptor D5 Rabbit anti-Mouse Polyclonal (aa19-56) Antibody
Application:
WB, Peptide-ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
Dopamine Receptor D5 antibody LS-C356637 is an unconjugated rabbit polyclonal antibody to mouse Dopamine Receptor D5 (DRD5) (aa19-56). Validated for Peptide-ELISA and WB.
Target
Mouse DRD5 / Dopamine Receptor D5
Synonyms
DRD5 | DRD1B | D(1B) dopamine receptor | D1b receptor | DBDR | DRD1L2 | Hd5dr
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purified
Specificity
This Drd5 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 19-56 amino acids from the N-terminal region of human Drd5.
Applications
- Western blot (1:2000)
- Peptide Enzyme-Linked Immunosorbent Assay
Presentation
PBS, 0.09% Sodium Azide
Storage
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About DRD5 / Dopamine Receptor D5
Featured Products
Species:
Human, Rat
Applications:
IHC, IHC - Paraffin
Species:
Human, Dog
Applications:
IHC, IHC - Paraffin
Species:
Rat, Mouse
Applications:
IHC, Western blot
Species:
Human
Applications:
Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Mouse
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024